COMPARATIVE ANALYSIS OF TYPE OF MYOCARDIAL INFARCTION IN PATIENTS WITH SUCCESSFUL OR UNSUCCESSFUL STREPTOKINASE THROMBOLYSIS FOLLOWING ST ELEVATION MYOCARDIAL INFARCTION
AbstractObjective: To study the effect of thrombolytic therapy in term of success and failure on the type of STelevation MI, using streptokinase. Material and Methods: This was a comparative study, conducted atDepartment of Cardiology, Lady Reading Hospital, Peshawar, from October 2006 to October 2007.Patients with first acute myocardial infarction were divided into group A (successful thrombolysis) andgroup B (unsuccessful thrombolysis) using ECG criteria. Results: Total number of patients were 200.Group A included 136 (68%) patients and group B included 64 (32%) patients. There were total 88(44%) patients of anterior MI with 47 patients in group A and 41 patients in group B (34.6% vs 64.0%,p<0.001). There were total 110 (55.0%) patients of inferior MI with 88 patients in group A and 22patients in group B (64.7% vs 34.4%, p<0.001). Lateral myocardial infarction was diagnosed in 2 (1%)patients with 1 patient each in group A and group B (0.7% vs 1.6%, p=0.583). Conclusion: AnteriorMI was associated with a higher rate of thromblysis failure while inferior MI and lateral wall MI wasassociated with a higher rate of successful thrombolysis.Keywords: Myocardial infarction; thrombolysis; type of myocardial infarction
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto
Miocardico (GISSI). Effectiveness of intravenous thrombolytic
treatment in acute myocardial infarction. Lancet 1986;1:397–402.
ISIS-2 (Second International Study of Infarct Survival)
Collaborative Group. Randomised trial of intravenous
streptokinase, oral aspirin, both, or neither among 17,187 cases of
J Ayub Med Coll Abbottabad 2012;24(1)
suspected acute myocardial infarction: ISIS-2. Lancet
De Belder MA. Coronary disease: acute myocardial infarction:
unsuccessful thrombolysis. Heart 2001;85:104–12.
Group FTTFC. Indications for fibrinolytic therapy in suspected
acute myocardial infarction: collaborative overview of early
mortality and major morbidity results from all randomised trials
of more than 1,000 patients. Lancet 1994;343:311–22.
Sutton AG, Campbell PG, Price DJ. Failure of thrombolysis by
streptokinase: detection with a simple electrocardiographic
method. Heart 2000;84:149–56.
Ahmad S, Qureshi MBA, Abbas MZ, Chaudhry MK, Ghani
MU. A comparative study of complications in patients of
myocardial infarction managed with and without streptokinase.
Pak J Cardiol 2004;15:61–7.
Topol EJ. Acute myocardial infarction:thrombolysis. A current
overview of the benefits and limitations of thrombolytic strategies
and the move towards combining thrombolytic agents with
glycoprotein IIb/IIIa receptor blockers. Heart 2000;83:122–6.
Hochman JS, Sleeper LA, White HD. One-year survival following
early revascularization for cardiogenic shock. JAMA
Bhatia L, Clesham GJ, Turner DR. Clinical implications of STsegment non-resolution after thrombolysis for myocardial
infarction. J R Soc Med 2004;97:566–70.
Henriques JPS, Zijlstra F, Van’t Hof AW. Primary percutaneous
coronary intervention versus thrombolytic treatment: long term
follow up according to infarct location. Heart 2006;92:75–9.
Prendergast BD, Shandall A, Buchalter MB. What do we do
when thrombolysis fails? A United Kingdom survey. Int J
An international randomized trial comparing four thrombolytic
strategies for acute myocardial infarction. The GUSTO
investigators. N Eng J Med 1993;329:673–82.
Lee YY, Tee MH, Zurkurnai Y, Than W, Sapawi M, Suhairi I.
Thrombolytic failure with streptokinase in acute myocardial
infarction using electrocardiogram criteria. Singapore Med J
Goldhammer E, Kharash L, Abinader EG. Circadian fluctuations
in the efficacy of thrombolysis with streptokinase. Postgrad Med
Brener SJ, Ellis SG, Sapp SK. Predictors of death and
reinfarction at 30 days after primary angioplasty: the GUSTO IIb
and RAPPORT trials. Am Heart J 2000;139:476–81.
Schröder R, Wegscheider K, Schröder K, Dissmann R, MeyerSabellek W. Extent of early ST segment elevation resolution: a
strong predictor of outcome in patients with acute myocardial
infarction and a sensitive measure to compare thrombolytic
regimens. A substudy of the International Joint Efficacy
Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol
Schroder R, Zeymer U, Wegscheider K, Neuhaus KL, for the
HIT-4 Trial Group. A substudy of the Hirudin for Improvement
of Thrombolysis (HIT)-4 Study. Comparison of the predictive
value of ST segment elevation resolution at 90 and 180 min after
start of streptokinase in acute myocardial infarction. Eur Heart J
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.